Xeris Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsXeris Pharmaceuticals

Xeris Pharmaceuticals(XERS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Keveyis	Dichlorphenamide	1982-01-01		Glaucoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

congenital hyperinsulinism

,

diabetes mellitus

,

glucose metabolism disorders

,

,

type 1 diabetes mellitus

healthy volunteers/patients

,

type 1 diabetes mellitus

,

insulin resistance

,

,

,

,

squamous cell carcinoma of head and neck

,

multiple myeloma

,

head and neck neoplasms

,

,

t-cell lymphoma peripheral

,

,

protein c deficiency

,

plasma cell neoplasms

,

neoplasm metastasis

,

rheumatoid arthritis

,

sleep initiation and maintenance disorders

,

intrinsic sleep disorders

,

granulosa cell tumor

,

wounds and injuries

,

traumatic brain injuries

,

craniocerebral trauma

,

,

colonic neoplasms

,

subarachnoid hemorrhage

,

colorectal neoplasms

,

chronic renal insufficiency

,

chronic kidney failure

,

,

,

,

von willebrand diseases

,

non-small-cell lung carcinoma

,

diabetes mellitus

,

primary immunodeficiency diseases

,

essential hypertension

,

,

,

,

,

ulcerative colitis

,

type 2 diabetes mellitus

,

thrombotic thrombocytopenic purpura

,

cardiovascular diseases

,

,

viral pneumonia

,

glucose metabolism disorders

,

,

prostatic neoplasms

,

,

,

ischemic stroke

,

large b-cell lymphoma diffuse

,

interdigitating dendritic cell sarcoma

,

chronic inflammatory demyelinating polyradiculoneuropathy

,

hodgkin disease

,

,

large-cell lymphoma anaplastic

,

,

precocious puberty

,

non-hodgkin lymphoma

,

,

alpha 1-antitrypsin deficiency

,

t-cell lymphoma

,

hematologic diseases

,

chronic obstructive pulmonary disease

,

mucopolysaccharidoses

,

mucopolysaccharidosis i

,

mucopolysaccharidosis ii

,

healthy volunteers/patients

,

renal insufficiency

,

critical illness

,

parkinson disease

,

cystic fibrosis

,

,

,

,

,

pituitary dwarfism

,

,

cardiovascular diseases

,

,

body weight changes

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

chronic obstructive pulmonary disease

,

gestational diabetes

,

nutrition disorders

,

cardiac surgical procedures

,

,

,

,

diabetes mellitus

,

type 2 diabetes mellitus

,

type 1 diabetes mellitus

,

,

drug delivery systems

,

insulin resistance

,

,

,

atherosclerosis

,

arteriosclerosis

,

,

diabetic ketoacidosis

,

chronic renal insufficiency

,

respiratory insufficiency

,

surgical wound infection

,

latent autoimmune diabetes in adults

,

heart disease risk factors

,

,

patient participation

,

sedentary behavior

type 1 diabetes mellitus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use